Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis including current skin involvement: results of a phase 3, randomized, controlled trial
Servizos
Servizos
Data de publicación
2013Título da revista
Annals of the rheumatic diseases
Tipo de contido
Publicación de congreso
